ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2095

Trends in Mortality and Disability-Adjusted Life Years (DALYs) from Osteoarthritis in the United States Compared to Global Estimates: A GBD-Based Analysis (1990–2021)

Khadija Mohib1, Rameez Qasim2, ZAUHA FAWAD MEMON3, Muhammad Asjad Saleem4, Matia Fawad Memon5 and Zaiya Waseem6, 1Kirk Kerkorian School of Medicine at UNLV, Las Vegas, NV, 2Allama Iqbal Medical College Lahore, Lahore, Pakistan, 3Peoples University of Medical and Health Sciences for Women, Tando Allahyar, Sindh, Pakistan, 4Indus Hospital Karachi, Karachi, 5Peoples University of Medical and Health Sciences for Women, Tando Allahyar, Pakistan, 6AtlantiCare Regional Medical Center, New Jersey

Meeting: ACR Convergence 2025

Keywords: Disability, Mortality, Osteoarthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, October 28, 2025

Title: (2079–2105) Osteoarthritis – Clinical Poster II

Session Type: Poster Session C

Session Time: 10:30AM-12:30PM

Background/Purpose: Osteoarthritis (OA) represents a growing public health concern, particularly among the aging population, contributing significantly to both mortality and Disability-Adjusted Life Years (DALYs). This study evaluates trends in OA-related DALY and mortality from 1990 to 2021, utilizing data from the Global Burden of Disease (GBD) database, with a comparative focus on the United States and global trends.

Methods: Data from the 2021 Global Burden of Disease (GBD) database were analyzed to evaluate osteoarthritis-related mortality and Disability-Adjusted Life Years (DALYs) among individuals aged 65 years and older in the United States and globally. DALY and mortality rates were reported per 100,000 population. Long-term trends from 1990 to 2021 were assessed using Annual Average Percentage Change (AAPC), with statistical significance determined by 95% confidence intervals (CIs) and p-values. Annual Percentage Change (APC) was also calculated for specific time intervals to identify periods of significant deviation from the overall trend.

Results: DALYs attributed to osteoarthritis showed a consistent upward trend globally, with a D-AAPC of 0.30% (95% CI: 0.28–0.31, p < 0.000001), observed similarly in both females (0.30%) and males (0.31%). Notably, a significant spike in DALY-APC (0.85%) was recorded between 2006 and 2009.In the United States, 44,590 OA-related deaths were reported between 1990 and 2021. The AAPC for mortality increased by 0.76% (95% CI: 0.11–0.41, p = 0.0215), aligning with the global trajectory. However, mortality trends showed fluctuations over time, with the lowest APC of -2.90% (95% CI: -3.93 to -1.18, p = 0.000035) between 2011 and 2018 and the highest APC of 13.03% (95% CI: 4.33–20.08, p = 0.0068).In the U.S., the D-AAPC over the last three decades increased by 1.68% (95% CI: 0.04–0.29, p = 0.0707), with a gender-specific increase of 0.12% for men and 0.24% for women. Several intervals showed declining mortality rates, notably between 1993–1996, 1996–1999, and 1999–2005 with D-APCs of -0.11%, -2.19%, and -1.08% respectively.

Conclusion: This study demonstrates a rising burden of osteoarthritis, reflected in both DALY and mortality trends, in the United States and globally over the past three decades. While some fluctuations exist, the overall trajectory suggests worsening impact, especially among older adults. These findings underscore the urgent need for targeted prevention strategies, improved access to musculoskeletal care, and investment in early intervention programs to reduce long-term disability and mortality. Further research is warranted to identify modifiable risk factors and health system inefficiencies contributing to these escalating trends.


Disclosures: K. Mohib: None; R. Qasim: None; Z. MEMON: None; M. Saleem: None; M. Memon: None; Z. Waseem: None.

To cite this abstract in AMA style:

Mohib K, Qasim R, MEMON Z, Saleem M, Memon M, Waseem Z. Trends in Mortality and Disability-Adjusted Life Years (DALYs) from Osteoarthritis in the United States Compared to Global Estimates: A GBD-Based Analysis (1990–2021) [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/trends-in-mortality-and-disability-adjusted-life-years-dalys-from-osteoarthritis-in-the-united-states-compared-to-global-estimates-a-gbd-based-analysis-1990-2021/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/trends-in-mortality-and-disability-adjusted-life-years-dalys-from-osteoarthritis-in-the-united-states-compared-to-global-estimates-a-gbd-based-analysis-1990-2021/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology